Breaking News
Get 45% Off 0
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Yes, You Can Time The Market. Find Out How - March 25, 2020 By Zacks Investment Research - Mar 24, 2020

There is no better feeling for an investor than trusting your gut or doing your research and timing the markets correctly, right?In fact, even among long-term investors who don't attempt to time the...

When Does Market Timing Actually Work? - March 25, 2020 By Zacks Investment Research - Mar 24, 2020

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?Indeed, even among those investors who don't try to consistently time the markets, many...

5 Best-Performing ETFs Of Dow's Biggest Rally In 87 Years By Zacks Investment Research - Mar 24, 2020

After days of relentless slide, the U.S. equity market showed a strong rebound with Dow Jones rising more than 11%, recording its best day since 1933. The S&P 500 Index had its strongest session...

Avoid These 3 Mutual Fund Misfires - March 25, 2020 By Zacks Investment Research - Mar 24, 2020

Does your current advisor have your money invested in these "Mutual Fund Misfires of the Market" that charge high fees for low returns? If so, it may be time for a new advisor.The easiest way to judge...

3 Mutual Fund Misfires To Avoid - March 25, 2020 By Zacks Investment Research - Mar 24, 2020

If your financial advisor made you buy any of these "Mutual Fund Misfires of the Market" with high expenses and low returns, you need to reassess your advisor.High fees plus poor performance: It's a...

Intel (INTC) Halts Share Buyback On Coronavirus Concerns By Zacks Investment Research - Mar 24, 2020

Intel (NYSE:T) becomes the latest S&P 500 company to bear the brunt of ongoing coronavirus pandemic. Per the 8K filed with the SEC, the chipmaker revealed that it is suspending stock repurchases...

Mutual Fund Misfires Of The Market - March 25, 2020 By Zacks Investment Research - Mar 24, 2020

If your financial advisor made you buy any of these "Mutual Fund Misfires of the Market" with high expenses and low returns, you need to reassess your advisor.High fees plus poor performance: It's a...

New York Tracks Peak Contagion, Durable Goods +1.2% By Zacks Investment Research - Mar 24, 2020

Wednesday, March 25, 2020Halfway through another trading week, and following the biggest single-day market gain on the Dow since 1933, pre-market futures are moderate and mixed. Yesterday’s...

Paychex (PAYX) Q3 Earnings & Revenues Surpass Estimates By Zacks Investment Research - Mar 24, 2020

Paychex, Inc. (NASDAQ:PAYX) reported solid third-quarter fiscal 2020 results wherein both earnings and revenues surpassed the Zacks Consensus Estimate.Adjusted earnings of 97 cents per share...

CytomX & Astellas Collaborate To Develop Novel Cancer Therapy By Zacks Investment Research - Mar 24, 2020

CytomX Therapeutics, Inc. (NASDAQ:CTMX) and Japan-based Astellas Pharma entered into a strategic collaboration for discovering, developing and commercialization of novel T-cell engaging bispecific...

Non Ferrous Metal Mining Industry Near-Term Outlook Bright By Zacks Investment Research - Mar 24, 2020

The Zacks Mining - Non Ferrous industry comprises companies that produce non-ferrous metals, including copper, gold, silver, cobalt, molybdenum, zinc, aluminum and uranium. These metals are utilized...

Pfizer's Eczema Drug Eucrisa Gets FDA Approval For Infants By Zacks Investment Research - Mar 24, 2020

Pfizer Inc. (NYSE:PFE) announced that the FDA has approved a supplemental new drug application (sNDA) for its eczema drug, Eucrisa (crisaborole) ointment, 2%. The sNDA sought label expansion of...

Continue with Apple
Continue with Google
or
Sign up with Email